Investigation of the effect of paracetamol against glutamate-induced cytotoxicity in C6 glia cells
Abstract
Paracetamol is an active metabolite with analgesic and antipyretic properties of phenacetin, which is sold without a prescription in our country and in many countries. However, the effect of paracetamol on oxidative stress due to glutamate-induced cytotoxicity remains unclear. This study aims to investigate the effect of an appropriate dose of paracetamol on nitric oxide and increased oxidative stress as a result of glutamate-induced cytotoxicity in C6 cells. The cells were divided into 4 groups as Control group, Glutamate group, Paracetamol group, and Paracetamol+Glutamate group. Cell viability rate between groups was measured by XTT assay. Oxidative stress and antioxidant levels were measured with TOS and TAS elisa kits. Paracetamol at all concentrations significantly increased cell viability in C6 cells (p < 0.001). Paracetamol also increased TAS levels (p <0.01) while significantly decreased TOS levels (p < 0.001). In addition, paracetamol was observed to decrease TNF-α and NO levels (p <0.001). In conclusion, paracetamol has protective feature on glutamate-induced cytotoxicity in C6 glial cells by suppressing oxidative stress. The results of this study show that when the appropriate dose of paracetamol is used, it can be a crucial promoter agent in glutamate toxicity-induced neurodegeneration.
Keywords
Paracetamol, Glutamate-toxicity, Oxidative stress, Nitric oxide, C6 cell.
Thanks
The authors would like to thank the CUTFAM Research Center, Sivas Cumhuriyet University, School of Medicine, Sivas, Turkey, for providing the necessary facilities to conduct this study.
References
- [1] Gündoğdu G., Şenol O., Demirkaya A.K., Glutamat Eksitotoksisitesi Oluşturulan Primer Kortikal Nöron Kültürlerinde Parietinin Nöroprotektif Etkisinin İncelenmesi, Atatürk Üniversitesi Veteriner Bilimleri Dergisi, 13(2) (2018) 165-173.
- [2] Lewerenz J., Maher P., Chronic Glutamate Toxicity in Neurodegenerative Diseases-What Is the Evidence?, Front Neurosci., 9 (2015) 469.
- [3] Rego A.C., Oliveira C.R., Mitochondrial Dysfunction and Reactive Oxygen Species in Excitotoxicity and Apoptosis: Implications for the Pathogenesis of Neurodegenerative Diseases, Neurochem Res., 28(10) (2003) 1563-1574.
- [4] Taşkın T., Dogan M., Yilmaz B.N., Senkardes I., Phytochemical screening and evaluation of antioxidant, enzyme inhibition, anti-proliferative and calcium oxalate anti-crystallization activities of Micromeria fruticosa spp. brachycalyx and Rhus coriaria, Biocatalysis and Agricultural Biotechnology, 27 (2020) 1-7.
- [5] Butterfield D.A. Pocernich C.B., The Glutamatergic System and Alzheimer's Disease: Therapeutic Implications, CNS Drugs, 17(9) (2003) 641-652.
- [6] Wang J., Wang F., Mai D., Qu S., Molecular Mechanisms of Glutamate Toxicity in Parkinson's Disease, Front Neurosci., 14 (2020) 585584.
- [7] Yıldızhan K., Nazıroğlu M., Microglia and Its Role in Neurodegenerative Diseases, Journal of Cellular Neuroscience and Oxidative Stress, 11(2) (2019) 861-873.
- [8] Penugonda S., Mare S., Goldstein G., Banks W.A., Ercal N., Effects of N-Acetylcysteine Amide (NACA), a Novel Thiol Antioxidant against Glutamate-Induced Cytotoxicity in Neuronal Cell Line Pc12, Brain Res., 1056(2) (2005) 132-138.
- [9] Yildizhan K., Naziroglu M., Glutathione Depletion and Parkinsonian Neurotoxin Mpp(+)-Induced Trpm2 Channel Activation Play Central Roles in Oxidative Cytotoxicity and Inflammation in Microglia, Mol. Neurobiol., 57(8) (2020) 3508-3525.
- [10] Wen X., Huang A., Hu J., Zhong Z., Liu Y., Li Z., Neuroprotective Effect of Astaxanthin against Glutamate-Induced Cytotoxicity in HT22 Cells: Involvement of the Akt/Gsk-3beta Pathway, Neuroscience, 303 (2015) 558-568.